|
Market Cap (5-Jun) $15,812,900 (1,318th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 2,106,389 |
Shortsold (23-Jan) 143,231 (0.01%) (538th) |
|
52w High $0.029 |
52w Low $0.010 |
P/E - |
EPS 0 |
NTI released this announcement to the ASX on 15 September 2022, 9:48. The announcement is not marked as price sensitive, and is 2 page(s) in length and 142.98kb in size.
You can view all announcements from NTI and see how they appear on a price chart on the announcements page.
At the date of this announcement, NTI was 0.096% short sold according to ASIC data. It was ranked the 485th most shorted stock on the ASX. It remains ranked 538th as of the latest reported data (23 January 2026).
| Other Recent Announcements from NTI | |
|---|---|
| Notification of cessation of securities - NTI | 30 June 2023, 17:06 |
| Notification regarding unquoted securities - NTI | 28 June 2023, 16:14 |
| NTI to Present at Rett Syndrome Foundation Meeting | 5 June 2023, 8:27 |
| Autism Spectrum Disorder Phase I/II Clinical Trial Update | 15 September 2022, 9:48 |
| NTI to Present at ASX Small to Mid-Cap Investor Conference | 9 September 2022, 12:55 |
| Initial Director's Interest Notice | 8 September 2022, 13:51 |
| Application for quotation of securities - NTI | 6 September 2022, 17:00 |
You must be logged in to post a reply.
Neurotech International 